Drug or technology

RNA, Long Noncoding

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 16, 2026 · JOURNAL ARTICLE

MIR210HG promotes preeclampsia progression through CDHR5.

Hypertension in Pregnancy

A real result from a sound but limited single-centre observational study with in vitro validation, identifying a biomarker with potential diagnostic utility that needs prospective validation.

PromisingLu Zhang Micrornas Jine Xu

Reported

PE case group sample size88

Control group sample size81

CDHR5 upregulation in PE placenta…P = 0.004

JUN 9, 2026 · JOURNAL ARTICLE

The regulatory roles of non-coding RNAs in aerobic glycolysis and therapeutic potential in pancreatic ductal adenocarcinoma.

Annals of Medicine

Narrative review summarizing mechanistic roles of non-coding RNAs in PDAC glycolysis without presenting original data or systematic meta-analysis.

Hypothesis-GeneratingYixu Fan Micrornas Yuan Fang

Reported

Five-year survival rate (PDAC ove…below 10%

Five-year survival rate (advanced…approximately 8.5%

Annual new PDAC casesapproximately 60,000

MAY 26, 2026 · JOURNAL ARTICLE

Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis.

Cancer Biology & Therapy

In vitro and database study identifying lncRNA AC008406.3 as a cuproptosis regulator affecting docetaxel sensitivity in breast cancer cells, lacking clinical validation or human efficacy data.

PreliminaryLin Zhang Xenograft Model Antitumor Assays Lncrna

Study details

DesignIntegrated TCGA database analysis with in v…

InterventionAC008406.3 knockdown and overexpression in…

ComparatorControl cells without AC008406.3 manipulati…